It is worth noting that in cases of prostate cancer, the activation of the phosphatidylinositol-3-kinase (PI3K), protein kinase B (PKB/AKT), and mTOR-dependent pathways facilitates tumour formation, disease progression, and therapeutic resistance. Here, AKT1 is linked to neoplasm.